Quality Evaluation of English Mobile Applications for Gestational Diabetes: App Review using Mobile Application Rating Scale (MARS).

IF 2.4 Q3 ENDOCRINOLOGY & METABOLISM Current diabetes reviews Pub Date : 2021-01-01 DOI:10.2174/1573399816666200703181438
Sharareh R Niakan Kalhori, Morteza Hemmat, Tayebe Noori, Saeede Heydarian, Meysam Rahmani Katigari
{"title":"Quality Evaluation of English Mobile Applications for Gestational Diabetes: App Review using Mobile Application Rating Scale (MARS).","authors":"Sharareh R Niakan Kalhori,&nbsp;Morteza Hemmat,&nbsp;Tayebe Noori,&nbsp;Saeede Heydarian,&nbsp;Meysam Rahmani Katigari","doi":"10.2174/1573399816666200703181438","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Mobile applications and social media serve their users as convenient tools to improve and monitor diseases and conditions such as pregnancy. These tools also exert a positive impact on Gestational diabetes mellitus (GDM) self-management.</p><p><strong>Introduction: </strong>Despite the expansion of mobile health apps for the management of GDM, no study has evaluated these apps using a valid tool. This study aimed to search and review the apps developed for this purpose, providing overall and specific rating scores for each aspect of MARS.</p><p><strong>Methods: </strong>Two cases of app stores (IOS and Google Play) were searched in January 2019 for apps related to GDM. Search keywords included \"gestational diabetes\", \"pregnant diabetes\", and \"Health apps\". Eligibility criteria include: capable of running on Android or IOS operating systems, in the English language, especially for GDM, and available in Iran. After removal of duplicates, the apps were reviewed, rated, and evaluated independently by two reviewers with Mobile App Rating Scale (MARS) tools.</p><p><strong>Results: </strong>Initially, 102 apps were identified after the exclusion process, five selected apps were downloaded and analyzed. All apps were classified into four categories according to contents and their interactive capabilities. In most quadrants of MARS, the Pregnant with Diabetes app received the highest scores. Also, in general, the maximum app quality mean score belonged to Pregnant with Diabetes (3.10 / 5.00).</p><p><strong>Conclusion: </strong>Findings revealed that apps designed for GDM are small in number and poor in quality based on MARS tools. Therefore, considering pregnant women's need for using the capabilities of these apps in pregnancy management and promoting community-based care, it seems essential to develop and design a series of high-quality apps in all four specified categories (only giving comments, obtaining data and giving comments, diagnosis of GDM, and diet calculator).</p>","PeriodicalId":10825,"journal":{"name":"Current diabetes reviews","volume":"17 2","pages":"161-168"},"PeriodicalIF":2.4000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"17","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current diabetes reviews","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1573399816666200703181438","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 17

Abstract

Background: Mobile applications and social media serve their users as convenient tools to improve and monitor diseases and conditions such as pregnancy. These tools also exert a positive impact on Gestational diabetes mellitus (GDM) self-management.

Introduction: Despite the expansion of mobile health apps for the management of GDM, no study has evaluated these apps using a valid tool. This study aimed to search and review the apps developed for this purpose, providing overall and specific rating scores for each aspect of MARS.

Methods: Two cases of app stores (IOS and Google Play) were searched in January 2019 for apps related to GDM. Search keywords included "gestational diabetes", "pregnant diabetes", and "Health apps". Eligibility criteria include: capable of running on Android or IOS operating systems, in the English language, especially for GDM, and available in Iran. After removal of duplicates, the apps were reviewed, rated, and evaluated independently by two reviewers with Mobile App Rating Scale (MARS) tools.

Results: Initially, 102 apps were identified after the exclusion process, five selected apps were downloaded and analyzed. All apps were classified into four categories according to contents and their interactive capabilities. In most quadrants of MARS, the Pregnant with Diabetes app received the highest scores. Also, in general, the maximum app quality mean score belonged to Pregnant with Diabetes (3.10 / 5.00).

Conclusion: Findings revealed that apps designed for GDM are small in number and poor in quality based on MARS tools. Therefore, considering pregnant women's need for using the capabilities of these apps in pregnancy management and promoting community-based care, it seems essential to develop and design a series of high-quality apps in all four specified categories (only giving comments, obtaining data and giving comments, diagnosis of GDM, and diet calculator).

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
妊娠期糖尿病英文移动应用质量评价:使用移动应用评分量表(MARS)进行应用评价。
背景:移动应用程序和社交媒体为用户提供了改善和监测疾病和状况(如怀孕)的便捷工具。这些工具对妊娠期糖尿病(GDM)的自我管理也有积极的影响。导言:尽管用于GDM管理的移动健康应用程序越来越多,但没有研究使用有效的工具对这些应用程序进行评估。本研究旨在搜索和审查为此目的开发的应用程序,为MARS的每个方面提供总体和具体的评级分数。方法:于2019年1月在两家应用商店(IOS和Google Play)中搜索与GDM相关的应用。搜索关键词包括“妊娠糖尿病”、“妊娠糖尿病”和“健康应用”。资格标准包括:能够在Android或IOS操作系统上运行,英语语言,特别是GDM,并且在伊朗可用。删除重复应用后,由两名评论者使用移动应用评级量表(MARS)工具对应用进行独立审查、评级和评估。结果:最初,经过排除过程,确定了102个应用程序,并下载了五个选定的应用程序并进行了分析。根据内容和交互能力,所有应用程序被分为四类。在MARS的大多数象限中,怀孕糖尿病应用程序获得了最高分。此外,总体而言,应用程序质量平均得分最高的是孕妇糖尿病(3.10 / 5.00)。结论:基于MARS工具,针对GDM设计的app数量少,质量差。因此,考虑到孕妇需要利用这些应用程序在妊娠管理和促进社区护理方面的功能,在所有四个指定类别(仅给出评论,获取数据并给出评论,GDM诊断,饮食计算器)中开发和设计一系列高质量的应用程序似乎是必要的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Current diabetes reviews
Current diabetes reviews ENDOCRINOLOGY & METABOLISM-
CiteScore
6.30
自引率
0.00%
发文量
158
期刊介绍: Current Diabetes Reviews publishes frontier reviews on all the latest advances on diabetes and its related areas e.g. pharmacology, pathogenesis, complications, epidemiology, clinical care, and therapy. The journal"s aim is to publish the highest quality review articles dedicated to clinical research in the field. The journal is essential reading for all researchers and clinicians who are involved in the field of diabetes.
期刊最新文献
Circulating Biomarkers as a Window into the Relationship between Sarcopenia and Diabetes: Implications for Effective Management. Unraveling the Mystery: COVID-19 and Diabetic Complications - A Journey from Pathophysiology to Treatment. WITHDRAWN: Histological and In Vivo Study on Novel Polyelectrolyte Complex Vildagliptin Loaded Microbeads in Streptozotocin-induced Rat Model WITHDRAWN: Prevalence and Predictors of Albuminuria in Type 2 Diabetes Mellitus Patients: A Cross-Sectional Study from the United Arab Emirates Association of ABO Gene rs2073823 Polymorphism with Microvascular Complications, sP-Selectin Levels and Lipid Profile in Type 2 Diabetes.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1